Lindbrook Capital, LLC
- SEC CIK
- 0001767045
- Latest filing
- May 5, 2025
TCRR holding history
TCR2 Therapeutics Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TCRR overviewAll 13F holders of TCRRFull Q1 2025 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −3,050−100.0% | Sold out | Holders |
| Q1 2023 | 3,050 | $4.58K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 3,050 | $3.05K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 3,050 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 3,050 | $9.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 3,050 | $8.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 3,050 | $14.0K | <0.1% | +3,050 | New | Holders |